Luciferase, firefly is the light-emitting enzyme responsible for the bioluminescence of fireflies and click beetles.
Luciferase, firefly is a bioluminescent enzyme derived from the North American firefly Photinus pyralis, renowned for its ability to catalyze the oxidation of luciferin in the presence of ATP and oxygen, resulting in the emission of visible light. As a quintessential reporter enzyme in molecular biology, it has become indispensable for sensitive detection and quantification of biological processes. Its unique capacity for producing light in a highly specific and ATP-dependent manner underpins its widespread adoption in a variety of research disciplines, including gene expression analysis, cell signaling studies, and high-throughput screening. The enzyme's biochemical properties, such as its rapid kinetics and high signal-to-noise ratio, make it a preferred choice for applications requiring real-time monitoring and quantitative readouts.
Reporter gene assays: Firefly luciferase is extensively utilized as a reporter gene in molecular and cellular biology to monitor transcriptional and translational activity. By integrating the luciferase gene downstream of a promoter of interest, researchers can quantitatively assess promoter strength, gene regulation, and the effects of transcription factors or regulatory elements. The emitted bioluminescence provides a direct and highly sensitive measure of gene expression levels, enabling rapid and non-destructive analysis in both transient and stable transfection experiments.
Cell viability and cytotoxicity assays: The ATP-dependence of firefly luciferase activity forms the basis for sensitive cell viability and cytotoxicity assays. In these applications, the enzyme serves as a probe for intracellular ATP levels, which correlate closely with metabolically active, viable cells. By measuring bioluminescent output upon addition of luciferin substrate, researchers can rapidly evaluate cell proliferation, assess the impact of test compounds, and perform high-throughput drug screening with minimal background interference.
Protein-protein interaction studies: The split-luciferase complementation approach leverages the modular structure of firefly luciferase to study protein-protein interactions in live cells. By fusing complementary fragments of the enzyme to candidate proteins, the reconstitution of enzymatic activity upon interaction leads to measurable light emission. This technique enables dynamic, real-time monitoring of molecular interactions, providing valuable insights into signaling pathways, protein complexes, and interaction kinetics in physiologically relevant environments.
In vivo imaging: The bioluminescent properties of firefly luciferase have been harnessed for noninvasive imaging of biological processes in living organisms. Through the introduction of luciferase-expressing constructs into animal models, researchers can visualize tumor growth, track cell migration, or monitor gene expression patterns over time. The high sensitivity and low background of bioluminescence imaging facilitate longitudinal studies and quantitative analysis, advancing research in oncology, developmental biology, and regenerative medicine.
Enzyme kinetics and inhibitor screening: Firefly luciferase serves as a robust model enzyme for investigating enzyme kinetics and evaluating potential inhibitors. Its well-characterized catalytic mechanism and straightforward assay format allow for precise determination of kinetic parameters, such as Km and Vmax, under various experimental conditions. Furthermore, the enzyme's sensitivity enables high-throughput screening of chemical libraries for modulators of luciferase activity, supporting drug discovery and the development of novel biochemical tools.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More